Research programme: estrogen receptor alpha modulators - Chemizon/Shenogen
Latest Information Update: 16 Jul 2016
At a glance
- Originator Chemizon; Shenogen Pharma
- Class Small molecules
- Mechanism of Action Estrogen receptor alpha modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Breast cancer; Osteoporosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Osteoporosis in USA (PO)
- 16 Jul 2016 No recent reports of development identified for research development in Breast-cancer(Late-stage disease, Metastatic disease) in USA (PO)
- 11 Feb 2010 Early research in Osteoporosis in USA (PO)